Cargando…
Fluorescent CXCR4 chemokine receptor antagonists: metal activated binding
The copper(ii) complex of a novel rhodamine-azamacrocycle conjugate binds to the CXCR4 chemokine receptor and competes effectively against anti-CXCR4 monoclonal antibodies. The copper macrocycle unit adopts a trans-II configuration in the solid state.
Autores principales: | Khan, Abid, Silversides, Jon D., Madden, Leigh, Greenman, John, Archibald, Stephen J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913474/ https://www.ncbi.nlm.nih.gov/pubmed/17220989 http://dx.doi.org/10.1039/b614557d |
Ejemplares similares
-
Small-Molecule
Fluorescent Ligands for the CXCR4 Chemokine
Receptor
por: Dekkers, Sebastian, et al.
Publicado: (2023) -
Exploratory Studies on Development of the Chemokine Receptor CXCR4 Antagonists Toward Downsizing
por: Tamamura, Hirokazu, et al.
Publicado: (2008) -
Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t
por: Ward, Richard J., et al.
Publicado: (2020) -
Copper(ii) cyclam-based complexes for radiopharmaceutical applications: synthesis and structural analysis
por: Silversides, Jon D., et al.
Publicado: (2007) -
Mechanism of Peptide Agonist Binding in CXCR4 Chemokine Receptor
por: Pawnikar, Shristi, et al.
Publicado: (2022)